140 related articles for article (PubMed ID: 29914304)
1. Neopterin as a novel marker; well correlated with mortality and morbidity in patients with advanced systolic heart failure.
Demir Ş; Ede H; Kaplan M; Yavuz F; Yücel C; Kurt İH
Acta Cardiol; 2019 Jun; 74(3):216-221. PubMed ID: 29914304
[No Abstract] [Full Text] [Related]
2. Long-term statin therapy in patients with systolic heart failure and normal cholesterol: effects on elevated serum markers of collagen turnover, inflammation, and B-type natriuretic peptide.
Abulhul E; McDonald K; Martos R; Phelan D; Spiers JP; Hennessy M; Baugh J; Watson C; O'Loughlin C; Ledwidge M
Clin Ther; 2012 Jan; 34(1):91-100. PubMed ID: 22154198
[TBL] [Abstract][Full Text] [Related]
3. Inflammatory activation following interruption of long-term cardiac resynchronization therapy.
Rubaj A; Ruciński P; Oleszczak K; Trojnar MK; Wójcik M; Wysokiński A; Kutarski A
Heart Vessels; 2013 Sep; 28(5):583-8. PubMed ID: 23242167
[TBL] [Abstract][Full Text] [Related]
4. Acute systolic heart failure with normal admission BNP: clinical features and outcomes.
Omar HR; Guglin M
Int J Cardiol; 2017 Apr; 232():324-329. PubMed ID: 28094130
[TBL] [Abstract][Full Text] [Related]
5. The novel diagnostic marker in low-LVEF heart failure patients.
Demir S; Ede H; Kaplan M; Yavuz F; Yucel C; Kurt IH
Bratisl Lek Listy; 2018; 119(7):421-424. PubMed ID: 30160130
[TBL] [Abstract][Full Text] [Related]
6. Effects of ivabradine therapy on heart failure biomarkers.
Ordu S; Yildiz BS; Alihanoglu YI; Ozsoy A; Tosun M; Evrengul H; Kaftan HA; Ozhan H
Cardiol J; 2015; 22(5):501-9. PubMed ID: 25733317
[TBL] [Abstract][Full Text] [Related]
7. N-terminal fraction of pro-B-type natriuretic peptide versus clinical risk scores for prognostic stratification in chronic systolic heart failure.
Arzilli C; Aimo A; Vergaro G; Ripoli A; Senni M; Emdin M; Passino C
Eur J Prev Cardiol; 2018 May; 25(8):889-895. PubMed ID: 29569494
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the clinical utility of urocortin 1 in systolic heart failure.
Yildirim E; Keles I; Cakmak HA; Cosansu K; Can G; Ikitimur B
Kardiol Pol; 2014; 72(5):452-8. PubMed ID: 24408067
[TBL] [Abstract][Full Text] [Related]
9. Prediction of outcome by highly sensitive troponin T in outpatients with chronic systolic left ventricular heart failure.
Egstrup M; Schou M; Tuxen CD; Kistorp CN; Hildebrandt PR; Gustafsson F; Faber J; Goetze JP; Gustafsson I
Am J Cardiol; 2012 Aug; 110(4):552-7. PubMed ID: 22579083
[TBL] [Abstract][Full Text] [Related]
10. Transthoracic bioimpedance and brain natriuretic peptide assessment for prognostic stratification of outpatients with chronic systolic heart failure.
Malfatto G; Corticelli A; Villani A; Giglio A; Della Rosa F; Branzi G; Facchini M; Parati G
Clin Cardiol; 2013 Feb; 36(2):103-9. PubMed ID: 23377871
[TBL] [Abstract][Full Text] [Related]
11. Predictors of one-year outcomes in chronic heart failure: the portrait of a middle income country.
Gioli-Pereira L; Marcondes-Braga FG; Bernardez-Pereira S; Bacal F; Fernandes F; Mansur AJ; Pereira AC; Krieger JE
BMC Cardiovasc Disord; 2019 Nov; 19(1):251. PubMed ID: 31706288
[TBL] [Abstract][Full Text] [Related]
12. Soluble ST2 protein in the short-term prognosis after hospitalisation in chronic systolic heart failure.
Wojtczak-Soska K; Sakowicz A; Pietrucha T; Lelonek M
Kardiol Pol; 2014; 72(8):725-34. PubMed ID: 24846354
[TBL] [Abstract][Full Text] [Related]
13. Influence of atrial fibrillation on plasma von willebrand factor, soluble E-selectin, and N-terminal pro B-type natriuretic peptide levels in systolic heart failure.
Freestone B; Gustafsson F; Chong AY; Corell P; Kistorp C; Hildebrandt P; Lip GY
Chest; 2008 May; 133(5):1203-8. PubMed ID: 18339785
[TBL] [Abstract][Full Text] [Related]
14. Cystatin C levels are associated with the prognosis of systolic heart failure patients.
Gao C; Zhong L; Gao Y; Li X; Zhang M; Wei S
Arch Cardiovasc Dis; 2011 Nov; 104(11):565-71. PubMed ID: 22117908
[TBL] [Abstract][Full Text] [Related]
15. The preserved autonomic functions may provide the asymptomatic clinical status in heart failure despite advanced left ventricular systolic dysfunction.
Kocaman SA; Taçoy G; Ozdemir M; Açıkgöz SK; Cengel A
Anadolu Kardiyol Derg; 2010 Dec; 10(6):519-25. PubMed ID: 20952357
[TBL] [Abstract][Full Text] [Related]
16. Serum fetuin-A levels in patients with systolic heart failure.
Keçebaş M; Güllülü S; Sağ S; Beşli F; Açikgöz E; Sarandöl E; Aydinlar A
Acta Cardiol; 2014 Aug; 69(4):399-405. PubMed ID: 25181915
[TBL] [Abstract][Full Text] [Related]
17. The roles of a novel inflammatory neopterin in subjects with coronary atherosclerotic heart disease.
Lyu Y; Jiang X; Dai W
Int Immunopharmacol; 2015 Feb; 24(2):169-172. PubMed ID: 25479720
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of C-Reactive Protein Plasma Levels to Predict Exercise Intolerance in Patients With Chronic Systolic Heart Failure.
Canada JM; Fronk DT; Cei LF; Carbone S; Erdle CO; Abouzaki NA; Melchior RD; Thomas CS; Christopher S; Turlington JS; Trankle CR; Thurber CJ; Evans RK; Dixon DL; Van Tassell BW; Arena R; Abbate A
Am J Cardiol; 2016 Jan; 117(1):116-20. PubMed ID: 26546248
[TBL] [Abstract][Full Text] [Related]
19. The prognostic value of repeated measurement of N-terminal pro-B-type natriuretic peptide in patients with chronic heart failure due to left ventricular systolic dysfunction.
Kubánek M; Goode KM; Lánská V; Clark AL; Cleland JG
Eur J Heart Fail; 2009 Apr; 11(4):367-77. PubMed ID: 19179406
[TBL] [Abstract][Full Text] [Related]
20. Combination of ST2 and B-type natriuretic peptide in diabetic patients with acute heart failure: relation with ventricular stiffness and outcome.
Ruocco G; Evangelista I; Franci B; Lucani B; Martini S; Nuti R; Palazzuoli A
J Cardiovasc Med (Hagerstown); 2019 Feb; 20(2):81-90. PubMed ID: 30540645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
